Treatment of Autoimmune Myasthenia Gravis

A treatment protocol for autoimmune myasthenia gravis (MG), patients sero-positive for AChR antibodies, is proposed from the University of California, Davis, CA.

Bibliographische Detailangaben
1. Verfasser: J Gordon Millichap
Format: Artikel
Sprache:English
Veröffentlicht: Pediatric Neurology Briefs Publishers 2004-02-01
Schriftenreihe:Pediatric Neurology Briefs
Schlagworte:
Online Zugang:https://www.pediatricneurologybriefs.com/articles/1425